https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale in Turkey.pdf
Seller warrants good
and clear title in goods subject to the sale
(“Product”) and that the Product conforms at the
time of shipment to a Certificate of Analysis, a
Certificate of Compliance, or a Product
Specification Sheet, if any such document exists,
and other specifications signed by Seller
(“Specifications”).
Thereafter, Buyer automatically approves the
invoice.
7.
Buyer shall
not (re-) export or (re-) transfer or disclose,
directly or indirectly, any of the Products or Items
supplied by Seller and/or any Items incorporating
or processed from such Products, in breach of any
Trade Control laws, or, in the event an export
license or other approval is required from any
governmental authority or agency, without first
obtaining such license or approval.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the Kingdom of Saudi Arabia.pdf
Seller warrants good and clear title in
goods subject to the sale (“Product”) and that the Product conforms at the
time of shipment to a Certificate of Analysis, a Certificate of Compliance,
or a Product Specification Sheet, if any such document exists, and other
specifications signed by Seller (“Specifications”).
Thereafter, Buyer
automatically approves the invoice.
.
Buyer shall not (re-) export or (re-) transfer or disclose, directly or
indirectly, any of the Products or Items supplied by Seller and/or any Items
incorporating or processed from such Products, in breach of any Trade
Control laws, or, in the event an export license or other approval is required
from any governmental authority or agency, without first obtaining such
license or approval.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Italy.pdf
Garanzia Limitata Esclusiva
Without prejudice to Section 3, Seller warrants good and
clear title in goods subject to the sale (“Product”) and that the
Product conforms at the time of shipment to a Certificate of
Analysis, a Certificate of Compliance, or a Product
Specification Sheet, if any such document exists, and other
specifications signed by Seller (“Specifications”).
Thereafter, Buyer automatically
approves the invoice.
L'Acquirente non potrà (ri)esportare o (ri)trasferire o
divulgare, direttamente o indirettamente, alcun Prodotto o
such license or approval.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Brazil %28English and Spanish Translation%29.pdf
Seller warrants good and
clear title in goods subject to the sale (“Product”) and
that the Product conforms at the time of shipment to a
Certificate of Analysis or a Certificate of Compliance
or a Product Specification Sheet, if either such
document exists, and other specifications signed by
Seller (“Specifications”).
Thereafter, Buyer
automatically approves the invoice.
7.
Buyer shall not (re-)
export or (re-) transfer or disclose, directly or
indirectly, any of the Products or Items supplied by
Seller and/or any Items incorporating or processed
from such Products, in breach of any Trade Control
laws, or, in the event an export license or other
approval is required from any governmental authority
or agency, without first obtaining such license or
approval.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Guatemala %28English and Spanish Translation%29.pdf
Seller warrants
good and clear title in goods subject to the sale
(“Product”) and that the Product conforms at the
time of shipment to a Certificate of Analysis, a
Certificate of Compliance, or a Product
Specification Sheet, if any such document exists,
and other specifications signed by Seller
(“Specifications”).
Thereafter, Buyer automatically
approves the invoice.
7.
Buyer shall not (re-)
export or (re-) transfer or disclose, directly or
indirectly, any of the Products or Items supplied
by Seller and/or any Items incorporating or
processed from such Products, in breach of any
Trade Control laws, or, in the event an export
license or other approval is required from any
governmental authority or agency, without first
obtaining such license or approval.
https://www.avient.com/investor-center/news/polyone-host-investor-conference-call
the time required to consummate the acquisition of Clariant's color and additive masterbatch business; the satisfaction or waiver of conditions in the purchase agreements; any material adverse changes in Clariant's color and additive masterbatch business; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed acquisition of Clariant's color and additive masterbatch business; our ability to achieve the strategic and other objectives relating to the proposed acquisition of Clariant's color and additive masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's color and additive masterbatch business and achieve the expected results of the acquisition of Clariant's color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/investor-center/news/polyone-announces-exercise-option-purchase-additional-common-shares
masterbatch business; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the acquisitions; our ability to achieve the strategic and other objectives relating to the acquisitions, including any expected synergies; our ability to successfully integrate
https://www.avient.com/investor-center/news/avient-completes-acquisition-dsm-protective-materials-dyneema
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to successfully integrate the Avient Protective Materials business and achieve the expected results of the business, including without limitation, the acquisition being accretive; any material adverse changes in the business supporting the Distribution assets being sold; the ability to obtain required regulatory approvals and otherwise consummate the proposed sale of the Distribution business; our ability to achieve the strategic and other objectives relating to the Avient Protective Materials business and the proposed sale of the Distribution business; and other factors described in our Annual Report on Form 10-K for the year ended
https://www.avient.com/industries/healthcare/medical-devices-equipment/imaging-technology
Explore our solutions to help meet your design needs, performance criteria and regulatory approvals.
https://www.avient.com/news/polyone-expands-healthcare-portfolio-biomerics’-specialty-medical-solutions
These highly biocompatible polymers will enhance our ability to help our customers accelerate speed-to-market, meet or exceed product performance requirements and navigate regulatory approvals more confidently,” said Mark Crist, president, PolyOne Distribution.